By The METAvivor Advocacy Team As the legislative landscape in Washington D.C. shifts with the dawn of...
Raul Delapena Setiawan
In the high-stakes environment of human oncology, the Epidermal Growth Factor Receptor (EGFR) family of proteins has...
PENSACOLA, Florida — For the millions of individuals navigating the labyrinthine world of rare diseases, the path...
[City, State] – [Date] – QuartzBio, a pioneering force in clinical trial intelligence, today announced a significant...
A groundbreaking study has identified a potential new environmental risk factor for early-onset colorectal cancer (CRC), a...
By Editorial Staff In the landscape of terminal illness, the focus is often exclusively on the medical...
In a landmark development for critical care medicine, the US Food and Drug Administration (FDA) has granted...
In the spring of 2024, at eight weeks into her fifth pregnancy, 38-year-old Anuradha sat in her...
In a significant leap forward for pharmacogenomics, the National Institute for Health and Care Excellence (NICE) has...
A burgeoning body of medical research is challenging the traditional pharmacological approach to Alzheimer’s disease (AD), suggesting...
